Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VasSol is a medical technology company that specializes in the development of advanced neurovascular imaging software. Its core product, Non-invasive Optimal Vessel Analysis (NOVA), is an FDA-cleared software platform designed to quantify blood flow in the brain using standard Magnetic Resonance Angiography (MRA). By providing precise measurements of blood flow volume and velocity, NOVA assists clinicians in diagnosing and managing complex cerebrovascular conditions such as stroke, aneurysms, and vessel stenosis. The technology offers a non-invasive alternative to catheter-based angiography, reducing patient risk while providing critical hemodynamic data for surgical planning. VasSol's solutions are primarily utilized by neurosurgeons and neuroradiologists in academic and specialized clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VasSol.